Pfizer

Pfizer, UCSF partner to expand drug discovery capabilities

Thursday, June 6, 2013 10:22 AM

Pfizer has expanded its Centers for Therapeutic Innovation (CTI), which is dedicated to establishing partnerships with academic medical centers, into the development of small-molecule drug candidates through a partnership with the University of California, San Francisco (UCSF). This partnership provides investigators from UCSF with access to Pfizer's small-molecule drug development capabilities, working with Pfizer scientists with the goal of jointly translating basic research into drug candidates to bring new therapies to patients.

More... »

Sanford-Burnham, Pfizer collaborate to speed drug discovery

Wednesday, June 5, 2013 01:18 PM

Sanford-Burnham Medical Research Institute has partnered with Pfizer as part of Pfizer's focus on translational medicine. The Centers for Therapeutic Innovation (CTI) is Pfizer’s research unit dedicated to establishing global partnerships with academic research institutions.

More... »

UPM purchases Pfizer commercial manufacturing site

Monday, June 3, 2013 11:32 AM

UPM Pharmaceuticals, a Baltimore, Md.-based drug development and contract manufacturer, will acquire the 500,000-square-foot commercial manufacturing facility Pfizer currently operates in Bristol, Tenn.

More... »

PAREXEL honored with 2013 "Partnership Pioneers of the Year" Award

Monday, April 29, 2013 11:09 AM

PAREXEL International, a global biopharmaceutical services provider, has been named a recipient of the 2013 "Partnership Pioneers of the Year" award in recognition of its innovative strategic partnership with Pfizer and ICON.

More... »

Pfizer’s palbociclib gets FDA breakthrough label

Friday, April 12, 2013 02:37 PM

Pfizer’s investigational compound palbociclib (PD-0332991), an oral and selective inhibitor of cyclin dependent kinases (CDK) 4 and 6, has received Breakthrough Therapy designation by the FDA for the potential treatment of patients with breast cancer.

More... »

Tetragenetics, Pfizer form collaboration in SionX technology

Wednesday, April 3, 2013 02:48 PM

Tetragenetics, a 2012 Gates Foundation phase II grant recipient and an emerging biotechnology company focused on particle-based vaccines and expression of ion channel drug targets, has entered into a collaboration agreement with an option for an exclusive license with Pfizer.

More... »

INC Research appoints James Taylor as vice president of clinical development

Tuesday, March 19, 2013 08:00 AM

INC Research, a therapeutically focused global CRO, has appointed James Taylor as vice president of clinical development.

More... »

New Jersey to hire displaced pharmaceutical workers

Wednesday, March 13, 2013 02:08 PM

New Jersey has announced a financial hiring incentive to employers through the state Department of Labor and Workforce Development (LWD) if they hire and train former pharmaceutical industry employees. Employers willing to hire displaced pharmaceutical workers may reduce the cost to train new employees under this new on-the-job training program, which will reimburse each employer up to between 50% and 90% of a new hire’s salary for up to six months and a maximum of $14,000

More... »

Medicines Patent Pool collaborates with ViiV Healthcare

Friday, March 1, 2013 12:39 PM

The Medicines Patent Pool (MPP) has launched a collaboration with ViiV Healthcare—a joint venture of GlaxoSmithKline, Pfizer and Shionogi—to facilitate greater availability of critically needed medicines for children living with HIV.

More... »

CDRD Ventures inks new partnership with Pfizer

Tuesday, February 26, 2013 11:29 AM

Pfizer and CDRD Ventures (CVI), the commercialization vehicle of the Center for Drug Research and Development (CDRD), have formed a strategic collaboration designed to provide new resources to advance Canada’s most innovative and therapeutically promising health technologies towards commercialization.

More... »